APO Research
Talk to an analyst

APO RESEARCH · REPORT

Protein Glutamine Gamma Glutamyltransferase 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Protein Glutamine Gamma Glutamyltransferase 2 Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchProtein Glutamine Gamma Glutamyltransferase 2 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Protein Glutamine Gamma Glutamyltransferase 2 Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Protein Glutamine Gamma Glutamyltransferase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Protein Glutamine Gamma Glutamyltransferase 2 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Protein Glutamine Gamma Glutamyltransferase 2 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Protein Glutamine Gamma Glutamyltransferase 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Protein Glutamine Gamma Glutamyltransferase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Protein Glutamine Gamma Glutamyltransferase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Protein Glutamine Gamma Glutamyltransferase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Protein Glutamine Gamma Glutamyltransferase 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Protein Glutamine Gamma Glutamyltransferase 2 market include Catabasis Pharmaceuticals Inc and Zedira GmbH among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Protein Glutamine Gamma Glutamyltransferase 2 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Protein Glutamine Gamma Glutamyltransferase 2 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Protein Glutamine Gamma Glutamyltransferase 2 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Protein Glutamine Gamma Glutamyltransferase 2 market.

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Company

Catabasis Pharmaceuticals Inc

Zedira GmbH

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Type

ZED-1227

ERW-1041E

CAT-5571

Others

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Application

Hospital

Clinic

Others

Protein Glutamine Gamma Glutamyltransferase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Protein Glutamine Gamma Glutamyltransferase 2 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Protein Glutamine Gamma Glutamyltransferase 2 key companies, revenue, market share, and recent developments.

3. To split the Protein Glutamine Gamma Glutamyltransferase 2 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Protein Glutamine Gamma Glutamyltransferase 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Protein Glutamine Gamma Glutamyltransferase 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Protein Glutamine Gamma Glutamyltransferase 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protein Glutamine Gamma Glutamyltransferase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Protein Glutamine Gamma Glutamyltransferase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protein Glutamine Gamma Glutamyltransferase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Protein Glutamine Gamma Glutamyltransferase 2 industry.

Chapter 3: Detailed analysis of Protein Glutamine Gamma Glutamyltransferase 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Protein Glutamine Gamma Glutamyltransferase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Protein Glutamine Gamma Glutamyltransferase 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Protein Glutamine Gamma Glutamyltransferase 2 Industry Trends Table 2. Protein Glutamine Gamma Glutamyltransferase 2 Industry Drivers Table 3. Protein Glutamine Gamma Glutamyltransferase 2 Industry Opportunities and Challenges Table 4. Protein Glutamine Gamma Glutamyltransferase 2 Industry Restraints Table 5. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue Share by Company (2021-2026) Table 7. Global Protein Glutamine Gamma Glutamyltransferase 2 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Protein Glutamine Gamma Glutamyltransferase 2 Key Company Manufacturing Base & Headquarters Table 9. Global Protein Glutamine Gamma Glutamyltransferase 2 Company, Product Type & Application Table 10. Global Protein Glutamine Gamma Glutamyltransferase 2 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Protein Glutamine Gamma Glutamyltransferase 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ZED-1227 Table 15. Significant Companies of ERW-1041E Table 16. Significant Companies of CAT-5571 Table 17. Significant Companies of Others Table 18. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type (2021-2026) Table 22. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Significant Companies of Others Table 26. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application (2021-2026) Table 30. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application (2027-2032) Table 31. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Region (2021-2026) Table 34. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Region (2027-2032) Table 36. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Market Share by Country (2021-2026) Table 39. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Market Share by Country (2027-2032) Table 41. Catabasis Pharmaceuticals Inc Company Information Table 42. Catabasis Pharmaceuticals Inc Business Overview Table 43. Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio Table 45. Catabasis Pharmaceuticals Inc Recent Development Table 46. Zedira GmbH Company Information Table 47. Zedira GmbH Business Overview Table 48. Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio Table 50. Zedira GmbH Recent Development Table 51. Research Programs/Design for This Report Table 52. Authors List of This Report Table 53. Secondary Sources Table 54. Primary Sources List of Figures Figure 1. Protein Glutamine Gamma Glutamyltransferase 2 Product Image Figure 2. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Protein Glutamine Gamma Glutamyltransferase 2 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ZED-1227 Image Figure 8. ERW-1041E Image Figure 9. CAT-5571 Image Figure 10. Others Image Figure 11. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Others Image Figure 17. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application (2021-2032) Figure 20. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032) & (US$ Million) Figure 23. North America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032) & (US$ Million) Figure 29. South America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • ZED-1227
  • ERW-1041E
  • CAT-5571
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Catabasis Pharmaceuticals Inc
  • Zedira GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Protein Glutamine Gamma Glutamyltransferase 2 Market Dynamics
  1. 2.1 Protein Glutamine Gamma Glutamyltransferase 2 Industry Trends
  2. 2.2 Protein Glutamine Gamma Glutamyltransferase 2 Industry Drivers
  3. 2.3 Protein Glutamine Gamma Glutamyltransferase 2 Industry Opportunities and Challenges
  4. 2.4 Protein Glutamine Gamma Glutamyltransferase 2 Industry Restraints
3 Protein Glutamine Gamma Glutamyltransferase 2 Market by Company
  1. 3.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Company Revenue Ranking in 2025
  2. 3.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Revenue by Company (2021-2026)
  3. 3.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Company Ranking (2024-2026)
  4. 3.4 Global Protein Glutamine Gamma Glutamyltransferase 2 Company Manufacturing Base and Headquarters
  5. 3.5 Global Protein Glutamine Gamma Glutamyltransferase 2 Company Product Type and Application
  6. 3.6 Global Protein Glutamine Gamma Glutamyltransferase 2 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Protein Glutamine Gamma Glutamyltransferase 2 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Protein Glutamine Gamma Glutamyltransferase 2 Market by Type
  1. 4.1 Protein Glutamine Gamma Glutamyltransferase 2 Type Introduction
  2. 4.1.1 ZED-1227
  3. 4.1.2 ERW-1041E
  4. 4.1.3 CAT-5571
  5. 4.1.4 Others
  6. 4.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type
  7. 4.2.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Type (2021-2032)
  9. 4.2.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type (2021-2032)
5 Protein Glutamine Gamma Glutamyltransferase 2 Market by Application
  1. 5.1 Protein Glutamine Gamma Glutamyltransferase 2 Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application
  6. 5.2.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Application (2021-2032)
  8. 5.2.3 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application (2021-2032)
6 Protein Glutamine Gamma Glutamyltransferase 2 Regional Value Analysis
  1. 6.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032)
  7. 6.3.2 North America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032)
  10. 6.4.2 Europe Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032)
  16. 6.6.2 South America Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Protein Glutamine Gamma Glutamyltransferase 2 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Country, 2025 VS 2032
7 Protein Glutamine Gamma Glutamyltransferase 2 Country-level Value Analysis
  1. 7.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Protein Glutamine Gamma Glutamyltransferase 2 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Protein Glutamine Gamma Glutamyltransferase 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Catabasis Pharmaceuticals Inc
  2. 8.1.1 Catabasis Pharmaceuticals Inc Company Information
  3. 8.1.2 Catabasis Pharmaceuticals Inc Business Overview
  4. 8.1.3 Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Catabasis Pharmaceuticals Inc Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio
  6. 8.1.5 Catabasis Pharmaceuticals Inc Recent Developments
  7. 8.2 Zedira GmbH
  8. 8.2.1 Zedira GmbH Company Information
  9. 8.2.2 Zedira GmbH Business Overview
  10. 8.2.3 Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zedira GmbH Protein Glutamine Gamma Glutamyltransferase 2 Product Portfolio
  12. 8.2.5 Zedira GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst